The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $332,462 in first-year total cost, median $166,231.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OBT-C (55)]2
Most frequent institutions
- MAYO CLINIC ROCHESTER1
- UNIVERSITY OF NEW SOUTH WALES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein1R21CA226959-01 | LIU, TAO | UNIVERSITY OF NEW SOUTH WALES | $124,967 | ZRG1 |
| 2017 | PQ6: Role of Cellular Senescence in Late Effects of Childhood Cancer Therapy1R21CA215867-01 | BRAM, RICHARD J | MAYO CLINIC ROCHESTER, MN | $207,495 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.